Patients On Lilly’s Experimental Diabetes Drug Lost 15% Of Their Weight And Lowered Blood Sugar, Company Says
Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.
Source: www.forbes.com
Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.